ETHZilla Acquires 95 Manufactured‑Home Loans for Tokenization on Ethereum Layer‑2
- ETHZilla is buying 95 manufactured‑home loans and first‑lien mortgages for about $4.7M via ETHZilla Modular Mortgage LLC.
- ETHZilla plans to tokenize the portfolio on an Ethereum Layer‑2 and launch a Liquidity.io token late Feb/early March.
- ETHZilla expects roughly 10.36% annualized yield and calls this tokenization a repeatable framework for income assets.
ETHZilla expands manufactured‑housing tokenization effort
Acquisition and tokenization of 95 manufactured‑home loans
ETHZilla Corporation is acquiring 95 manufactured and modular home loans, together with the first‑lien mortgages securing them, from Zippy Manufactured Home Credit Fund I L.P. for about $4.7 million through its new wholly owned unit, ETHZilla Modular Mortgage LLC. The loans remain serviced by Zippy Loans LLC and form a seasoned residential credit pool that ETHZilla expects to generate roughly a 10.36% annualized yield from contractual interest payments. The company is positioning the portfolio as a recurring cash‑flow asset suitable for blockchain tokenization.
The company plans to tokenize the portfolio using Ethereum Layer‑2 infrastructure to enable on‑chain asset tracking and automated cash‑flow distribution to token holders. ETHZilla intends to launch the manufactured home loan token within the Liquidity.io ecosystem in late February or early March, using the token to represent pro rata rights to the pool’s contractual payments. The structure is presented as a regulated, transparent conduit to bring established income‑generating real‑world assets on‑chain while preserving servicing continuity with the originator.
The deal builds on a closer operating tie with Zippy: ETHZilla acquired roughly 15% of Zippy, Inc., the fund’s parent, in December 2025, which the company says strengthens access to origination, servicing and asset‑level expertise in manufactured housing finance. ETHZilla frames the transaction as part of a repeatable framework to securitize and tokenize differentiated income assets, with chairman and CEO McAndrew Rudisill calling the move a “natural extension of our disciplined approach” to bringing cash‑flow assets on‑chain within a transparent structure.
Other recent real‑world asset moves
The manufactured‑home loan purchase follows ETHZilla’s recent acquisition of two CFM56‑7B24 aircraft engines on lease with a major air carrier, assets the company also plans to tokenize and list on Liquidity.io as part of the same infrastructure play to broaden investor access to income‑oriented markets.
Operational and market implications
By combining a minority ownership stake in an originator, ongoing servicing relationships and Layer‑2 token mechanics, ETHZilla aims to lower frictions for institutional and accredited participants to access real‑world asset cash flows and to create a scalable pipeline across multiple asset classes. The company signals continued focus on regulated token launches and asset‑level transparency.
Related Cashu News

CRISPR Therapeutics AG Achieves Financial Progress Amid Advancements in Gene-Editing Portfolio
CRISPR Therapeutics AG (Ticker: UNDEFINED) showcases a pivotal moment in its financial journey with the release of its results for the first quarter of 2026. Highlighting a revenue of $1.46 million, t…

MetaVia to Present Innovative Cardiometabolic Research at 2026 ADA Scientific Sessions
MetaVia is set to showcase its innovative research in cardiometabolic diseases at the upcoming American Diabetes Association (ADA) Scientific Sessions in 2026, following the acceptance of three late-b…

Ionis Pharmaceuticals Advances TRYNGOLZA for Hypertriglyceridemia and Diranersen for Alzheimer's Disease
Ionis Pharmaceuticals has made headlines in the biotechnology sector with the promising potential of its drug TRYNGOLZA, which is designed to treat severe hypertriglyceridemia. During a recent healthc…

ImmunityBio Partners with BCG Laboratory to Enhance Bladder Cancer Treatment Supply and Options
ImmunityBio has secured a critical partnership with Japan's BCG Laboratory to enhance the supply of Bacillus Calmette-Guérin (BCG) in the United States, addressing an urgent need in the treatment of b…